Trumps Endorsement of Natural 7-OH Stirs Debate in Kratom Industry
Trumps Endorsement of Natural 7-OH Stirs Debate in Kratom Industry The FDA’s June 2026 warning letters target concentrated 7-hydroxymitragynine (7-OH) products such as tablets, gummies, and shots. That’s why a reputable vendor’s lab-tested, single-strain powder and capsules sit in a different regulatory category than the concentrated products drawing federal warning…